Chardan Capital analyst Daniil Gataulin maintains Forte Biosciences (NASDAQ:FBRX) with a Buy and maintains $64 price target.
- Headlines
- Chardan Capital Maintains Buy on Forte Biosciences, Maintains $64 Price Target
Chardan Capital Maintains Buy on Forte Biosciences, Maintains $64 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
05:01
Warner Bros. Discovery rose by 15%, achieving its best single-day performance in a year.
05:00
The year-on-year export price index of South Korea in November is 7%, compared to the previous value of 2.00%. The year-on-year import price index of South Korea in November is 3%, compared to the previous value of -2.50%.
05:00
China Concept Stocks had mixed performance on Thursday, and the Nasdaq China Golden Dragon Index rose by 0.16%.
.HXC+0.17%